These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3670697)

  • 1. [Evaluation of pharmacologic treatment associated with motor-activation therapy in the prevention of senile impairment].
    Belloi L; Pirani A; Bongiorno G; Melloni M; Dinelli M; Francia R; Gallerani A; Vecchi GP
    Minerva Med; 1987 Oct; 78(20):1543-50. PubMed ID: 3670697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of cognitive impairment secondary to degenerative dementia. Effectiveness of oxiracetam therapy.
    Rozzini R; Zanetti O; Bianchetti A
    Acta Neurol (Napoli); 1993 Feb; 15(1):44-52. PubMed ID: 8456595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of senile dementia associated with cerebrovascular insufficiency: a comparative study of buflomedil and dihydrogenated ergot alkaloids.
    Jansen W; Bruckner GW; Jansen P
    J Int Med Res; 1985; 13(1):48-53. PubMed ID: 3884411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of regular exercise on senile dementia patients.
    Kwak YS; Um SY; Son TG; Kim DJ
    Int J Sports Med; 2008 Jun; 29(6):471-4. PubMed ID: 18050054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A neuropsychological battery to detect specific executive and social cognitive impairments in early frontotemporal dementia.
    Torralva T; Roca M; Gleichgerrcht E; Bekinschtein T; Manes F
    Brain; 2009 May; 132(Pt 5):1299-309. PubMed ID: 19336463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Depression and frontal dysfunction: risks for the elderly?].
    Thomas P; Hazif Thomas C; Billon R; Peix R; Faugeron P; Clément JP
    Encephale; 2009 Sep; 35(4):361-9. PubMed ID: 19748373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A controlled clinical trial on the effects of motor intervention on balance and cognition in institutionalized elderly patients with dementia.
    Christofoletti G; Oliani MM; Gobbi S; Stella F; Bucken Gobbi LT; Renato Canineu P
    Clin Rehabil; 2008 Jul; 22(7):618-26. PubMed ID: 18586813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Activating ergotherapy--a method for increasing cognitive performance in geriatric patients].
    Bach D; Böhmer F; Frühwald F; Grilc B
    Z Gerontol; 1993; 26(6):476-81. PubMed ID: 8147083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Encephalotropic and psychotropic effects of intravenous buflomedil in the elderly: double-blind, placebo-controlled pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L; Stöhr H
    Int J Clin Pharmacol Res; 1984; 4(2):95-107. PubMed ID: 6469443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
    Lawlor BA
    J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social phobia. Longitudinal course and long-term outcome of cognitive-behavioral treatment.
    Juster HR; Heimberg RG
    Psychiatr Clin North Am; 1995 Dec; 18(4):821-42. PubMed ID: 8748383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Brain performance and behavior in senile dementias of the Alzheimer type].
    Schubert H
    Wien Klin Wochenschr Suppl; 1984; 150():1-48. PubMed ID: 6592881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-acetylcarnitine treatment of mental decline in the elderly.
    Salvioli G; Neri M
    Drugs Exp Clin Res; 1994; 20(4):169-76. PubMed ID: 7813389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive impairment and cardiovascular disease risk factors. Project CASCADE Kraków. I. Project to test exposure to risk factors for cardiovascular disease in the studied sample].
    Pajak A; Kawalec E; Szczudlik A
    Przegl Lek; 1998; 55(12):676-82. PubMed ID: 10354721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective cognitive complaints, neuropsychological performance, affective and behavioural symptoms in non-demented patients.
    Gallassi R; Bisulli A; Oppi F; Poda R; Di Felice C
    Int J Geriatr Psychiatry; 2008 Jan; 23(1):95-101. PubMed ID: 17879254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dementia following bipolar disorder].
    Lebert F; Lys H; Haëm E; Pasquier F
    Encephale; 2008 Dec; 34(6):606-10. PubMed ID: 19081458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.